US Patent Issued to NOVAROCK BIOTHERAPEUTICS on July 22 for "Anti-interleukin-23 P19 antibodies and methods of use thereof" (Pennsylvania, California, New Jersey Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,727, issued on July 22, was assigned to NOVAROCK BIOTHERAPEUTICS LTD. (Ewing, N.J.).

"Anti-interleukin-23 P19 antibodies and methods of use thereof" was invented by Haichun Huang (Fremont, Calif.), Ming Lei (Princeton, N.J.), Yi Pei (Paoli, Pa.) and Han Li (Newtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antibody fragments thereof that bind to IL-23p19. The disclosed antibodies and antibody fragments thereof can modulate a biological activity of the IL-23 receptor signaling axis and are therefore useful for the treatment of immune-mediated inflammatory disorders."

The patent was filed on Ju...